Chenyang Qi

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Histone Deacetylase

Systemic Sclerosis

Health Risk Assessment

Top Venues

Cell death & disease

Radiation protection dosimetry

This page only lists publications with an associated author ORCID identifier.

Publications

Wei Zhang, Chenyang Qi, David Lim, Xianpeng Zhang, Rihong Gao, Zhihui Feng
Health risk assessment for soil radioactivity around Shidaowan nuclear power plant in Shandong, China. Radiation protection dosimetry 200 (6) (2024)
Wei Zhang, Chenyang Qi, David Lim, Xianpeng Zhang, Rihong Gao, Zhihui Feng
Health risk assessment for soil radioactivity around Shidaowan nuclear power plant in Shandong, China. Radiation protection dosimetry (2024)
Wei Zhang, Chenyang Qi, David Lim, Xianpeng Zhang, Rihong Gao, Zhihui Feng
Health risk assessment for soil radioactivity around Shidaowan nuclear power plant in Shandong, China. Radiation protection dosimetry 200 (6) (2024)
Benyu Su, David Lim, Chenyang Qi, Zhongwei Zhang, Junxiao Wang, Fengmei Zhang, Chao Dong, Zhihui Feng
VPA mediates bidirectional regulation of cell cycle progression through the PPP2R2A-Chk1 signaling axis in response to HU. Cell death & disease 14 (2) (2023)
Benyu Su, David Lim, Chenyang Qi, Zhongwei Zhang, Junxiao Wang, Fengmei Zhang, Chao Dong, Zhihui Feng
VPA mediates bidirectional regulation of cell cycle progression through the PPP2R2A-Chk1 signaling axis in response to HU. Cell death & disease 14 (2) (2023)
Benyu Su, David Lim, Chenyang Qi, Zhongwei Zhang, Junxiao Wang, Fengmei Zhang, Chao Dong, Zhihui Feng
VPA mediates bidirectional regulation of cell cycle progression through the PPP2R2A-Chk1 signaling axis in response to HU. Cell death & disease 14 (2) (2023)
Benyu Su, David Lim, Chenyang Qi, Zhongwei Zhang, Junxiao Wang, Fengmei Zhang, Chao Dong, Zhihui Feng
VPA mediates bidirectional regulation of cell cycle progression through the PPP2R2A-Chk1 signaling axis in response to HU. Cell death & disease 14 (2) (2023)